Through iPSC haplobanks, researchers can develop off-the-shelf, allogeneic cell therapies tailored to patients’ genetic profiles. This innovation enhances regenerative medicine, reduces costs, and supports global access to personalized treatments using induced pluripotent stem cells. https://xelleratherapeutics.bcz.com/2025/10/27/how-ipsc-haplobanks-are-revolutionizing-cell-therapy-and-personalized-medicine/